Ausgabe 3/2013
Inhalt (17 Artikel)
Is the simultaneously integrated boost (SIB) technique for early breast cancer ready to be adopted for routine adjuvant radiotherapy?
F. Sedlmayer, M.L. Sautter-Bihl, W. Budach, J. Dunst, P. Feyer, R. Fietkau, W. Haase, W. Harms, C. Rödel, R. Souchon, F. Wenz, R. Sauer
Modification of staging and treatment of head and neck cancer by FDG-PET/CT prior to radiotherapy
A. Abramyuk, S. Appold, K. Zöphel, M. Baumann, N. Abolmaali
Cyclin D1, EGFR, and Akt/mTOR pathway
D. Dionysopoulos, K. Pavlakis, V. Kotoula, E. Fountzilas, K. Markou, I. Karasmanis, N. Angouridakis, A. Nikolaou, K.T. Kalogeras, G. Fountzilas
Xerostomia after radiotherapy
S. Tribius, J. Sommer, C. Prosch, A. Bajrovic, A. Muenscher, M. Blessmann, A. Kruell, C. Petersen, M. Todorovic, P. Tennstedt
Intensity-modulated radiotherapy vs. parotid-sparing 3D conformal radiotherapy
M. Lambrecht, D. Nevens, S. Nuyts
Dysphagia after definitive radiotherapy for head and neck cancer
L. Deantonio, L. Masini, M. Brambilla, F. Pia, M. Krengli
Residual tumour volumes and grey zones after external beam radiotherapy (with or without chemotherapy) in cervical cancer patients
M.P. Schmid, B. Mansmann, M. Federico, J.C.A. Dimopoulous, P. Georg, E. Fidarova, W. Dörr, R. Pötter
In vitro hypoxic cytotoxicity and hypoxic radiosensitization
M. Langenbacher, R.J. Abdel-Jalil, W. Voelter, M. Weinmann, S.M. Huber
Intraoperative radiotherapy and cytoreductive surgery with hyperthermic intraperitoneal chemotherapy
Y.L.B. Klaver, V.E.P.P. Lemmens, S.W. Nienhuijs, G.A.P. Nieuwenhuijzen, H.J.T. Rutten, I.H.J.T. de Hingh
Bestrahlungsdosen und Kataraktrate bei Überlebenden der Atombombe
Th. Herrmann
Hyperfraktionierte gegenüber konventionell fraktionierter Strahlentherapie beim nichtmetastasierten Medulloblastom
R.-D. Kortmann, H.-J. Ochel
Primäre kurative Radiochemotherapie beim Nasopharynxkarzinom
H. Christiansen, H.A. Wolff